160 related articles for article (PubMed ID: 9309400)
21. Karyometry in Barrett's esophagus.
da Silva VD; Prolla JC; Sharma P; Sampliner R; Thompson D; Bartels PH
Anal Quant Cytol Histol; 2001 Feb; 23(1):40-6. PubMed ID: 11233742
[TBL] [Abstract][Full Text] [Related]
22. Esophageal adenocarcinoma arising in cervical inlet patch with synchronous Barrett's esophagus-related dysplasia.
Tanaka M; Ushiku T; Ikemura M; Shibahara J; Seto Y; Fukayama M
Pathol Int; 2014 Aug; 64(8):397-401. PubMed ID: 25143128
[TBL] [Abstract][Full Text] [Related]
23. Potential application of p53 as an intermediate biomarker in Barrett's esophagus.
Jones DR; Davidson AG; Summers CL; Murray GF; Quinlan DC
Ann Thorac Surg; 1994 Mar; 57(3):598-603. PubMed ID: 8147627
[TBL] [Abstract][Full Text] [Related]
24. Is Barrett's metaplasia the source of adenocarcinomas of the cardia?
Clark GW; Smyrk TC; Burdiles P; Hoeft SF; Peters JH; Kiyabu M; Hinder RA; Bremner CG; DeMeester TR
Arch Surg; 1994 Jun; 129(6):609-14. PubMed ID: 8204035
[TBL] [Abstract][Full Text] [Related]
25.
Fang HY; Münch NS; Schottelius M; Ingermann J; Liu H; Schauer M; Stangl S; Multhoff G; Steiger K; Gerngroß C; Jesinghaus M; Weichert W; Kühl AA; Sepulveda AR; Wester HJ; Wang TC; Quante M
Clin Cancer Res; 2018 Mar; 24(5):1048-1061. PubMed ID: 29208671
[No Abstract] [Full Text] [Related]
26. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus.
Larghi A; Lightdale CJ; Memeo L; Bhagat G; Okpara N; Rotterdam H
Gastrointest Endosc; 2005 Jul; 62(1):16-23. PubMed ID: 15990814
[TBL] [Abstract][Full Text] [Related]
27. Atypical mitoses in dysplasias of the Barrett's mucosa.
Rubio CA; Riddell RH
Pathol Res Pract; 1988 Dec; 184(1):1-5. PubMed ID: 3231567
[TBL] [Abstract][Full Text] [Related]
28. Multilayered epithelium may be found in patients with Barrett's epithelium and dysplasia or adenocarcinoma.
Upton MP; Nishioka NS; Ransil BJ; Rosenberg SJ; Puricelli WP; Zwas FR; Shields HM
Dig Dis Sci; 2006 Oct; 51(10):1783-90. PubMed ID: 16967312
[TBL] [Abstract][Full Text] [Related]
29. Endoscopic features of esophageal adenocarcinoma derived from short-segment versus long-segment Barrett's esophagus.
Yamasaki A; Shimizu T; Kawachi H; Yamamoto N; Yoshimizu S; Horiuchi Y; Ishiyama A; Yoshio T; Hirasawa T; Tsuchida T; Sasaki Y; Fujisaki J
J Gastroenterol Hepatol; 2020 Feb; 35(2):211-217. PubMed ID: 31396997
[TBL] [Abstract][Full Text] [Related]
30. [Endoscopic diagnosis of Barrett's adenocarcinoma].
Yoshio H; Takashi Y; Mitsuyo H; Nobuhiko Y; Tatsurou T; Kazuhiko S; Yoko H; Shigemasa I; Hisanaga M; Osamu H; Katsuyoshi S; Seishi U; Matsushita H; Masahiko T
Nihon Geka Gakkai Zasshi; 1999 Mar; 100(3):244-8. PubMed ID: 10379534
[TBL] [Abstract][Full Text] [Related]
31. [Barrett's esophageal adenocarcinoma].
Nakamura T
Gan To Kagaku Ryoho; 2004 Mar; 31(3):322-6. PubMed ID: 15045933
[TBL] [Abstract][Full Text] [Related]
32. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
[TBL] [Abstract][Full Text] [Related]
33. The diagnosis and management of Barrett's esophagus.
DeMeester SR; DeMeester TR
Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
[TBL] [Abstract][Full Text] [Related]
34. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia.
Reid BJ; Blount PL; Feng Z; Levine DS
Am J Gastroenterol; 2000 Nov; 95(11):3089-96. PubMed ID: 11095322
[TBL] [Abstract][Full Text] [Related]
35. [Surveillance of patients with Barrett's esophagus].
Endlicher E; Knüchel R; Messmann H
Z Gastroenterol; 2001 Aug; 39(8):593-600. PubMed ID: 11558064
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L in Barrett's esophagus with dysplasia and adenocarcinoma.
Popnikolov NK; Gatalica Z; Adegboyega PA; Norris BA; Pasricha PJ
Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):161-5. PubMed ID: 16785783
[TBL] [Abstract][Full Text] [Related]
37. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
[TBL] [Abstract][Full Text] [Related]
38. Cytology in Barrett's esophagus.
Falk GW
Gastrointest Endosc Clin N Am; 2003 Apr; 13(2):335-48. PubMed ID: 12916664
[TBL] [Abstract][Full Text] [Related]
39. EUS in the management of the patient with dysplasia in Barrett's esophagus.
Savoy AD; Wallace MB
J Clin Gastroenterol; 2005 Apr; 39(4):263-7. PubMed ID: 15758616
[TBL] [Abstract][Full Text] [Related]
40. Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma.
Reid BJ; Haggitt RC; Rubin CE; Rabinovitch PS
Gastroenterology; 1987 Jul; 93(1):1-11. PubMed ID: 3582897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
